Clinic
Best Healthcare, INC
Best Healthcare, INC was paid $31.05M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoBEST HEALTHCARE, INC
MONROE, NY 10950
MONROE, NY 10950
33aNPI1609923671assigned 01/04/2007
33bProvider typeClinic/Center
28Total paid$31.05M
24GClaims474,884
24DCodes billed61
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in New York
Rank by total paid#6 of 235
Median peer was paid$630K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 72,290 | $3.08M | |
| 2019 | 82,242 | $3.75M | |
| 2020 | 68,192 | $4.46M | |
| 2021 | 65,182 | $5.10M | |
| 2022 | 56,176 | $4.39M | |
| 2023 | 62,947 | $5.07M | |
| 2024incomplete | 67,855 | $5.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 114,453 | 98,295 | $12.19M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 10% | 22,501 | 22,284 | $3.20M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 27,515 | 25,696 | $3.14M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.5% | 19,809 | 19,500 | $2.34M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.8% | 15,110 | 14,987 | $1.81M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.4% | 45,210 | 41,217 | $1.66M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.9% | 10,404 | 10,186 | $1.21M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.3% | 8,437 | 8,330 | $1.03M |
| 99173 | 2.6% | 11,805 | 11,770 | $804K | |
| 99381 | 1.5% | 3,943 | 3,893 | $464K | |
| 36416 | 1.3% | 10,770 | 10,423 | $399K | |
| 99051 | 1.2% | 28,357 | 27,171 | $359K |
49 more codes
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 2,407 | $267K |
| 69210 | <1% | 2,235 | $220K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 25,626 | $203K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 9,491 | $198K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,538 | $187K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 909 | $104K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,391 | $98K |
| 87081 | <1% | 27,458 | $94K | |
| 99441 | <1% | 750 | $89K | |
| 90633 | <1% | 5,130 | $83K | |
| 90670 | <1% | 6,549 | $78K | |
| 90723 | <1% | 5,360 | $72K | |
| 90710 | <1% | 4,259 | $70K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 5,267 | $65K |
| 90697 | <1% | 2,641 | $58K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,455 | $49K |
| 99442 | <1% | 378 | $44K | |
| 90734 | <1% | 2,587 | $43K | |
| 90696 | <1% | 2,494 | $43K | |
| 99000 | <1% | 1,206 | $41K | |
| 90700 | <1% | 2,045 | $36K | |
| 90715 | <1% | 2,002 | $36K | |
| 90648 | <1% | 3,574 | $31K | |
| 90677 | <1% | 1,200 | $30K | |
| 90686 | <1% | 2,416 | $29K | |
| 90671 | <1% | 887 | $19K | |
| 90744 | <1% | 990 | $17K | |
| 85018 | <1% | 11,589 | $16K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 719 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,073 | $15K |
| 90698 | <1% | 803 | $13K | |
| 90716 | <1% | 741 | $11K | |
| 90733 | <1% | 389 | $10K | |
| 36410 | <1% | 318 | $10K | |
| 90707 | <1% | 1,359 | $9K | |
| 81003 | <1% | 4,750 | $9K | |
| 90685 | <1% | 540 | $5K | |
| 17110 | <1% | 21 | $5K | |
| 90661 | <1% | 168 | $4K | |
| 81000 | <1% | 1,641 | $4K | |
| 90681 | <1% | 304 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 695 | $4K |
| 90688 | <1% | 197 | $4K | |
| 90658 | <1% | 95 | $2K | |
| 86580 | <1% | 219 | $2K | |
| 90657 | <1% | 15 | $357.14 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 26 | $343.98 |
| 90461 | <1% | 999 | $30.00 | |
| 87631 | 0% | 664 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWERZBERGER, ALAN (MEDICAL DIRECTOR)